Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1981 Feb;37(2):755–758. doi: 10.1128/jvi.37.2.755-758.1981

Convenient assay for interferons.

S Rubinstein, P C Familletti, S Pestka
PMCID: PMC171063  PMID: 6163873

Abstract

A convenient assay for interferons based on reduction of cytopathic effect was developed. The number of manipulations and the lengths of the various incubation steps were reduced to a minimum. The assay is simple to perform and can be completed within 16 h. Moreover, it can be used with various types of cells and a variety of viruses.

Full text

PDF
755

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. A. Semi-micro, dye-binding assay for rabbit interferon. Appl Microbiol. 1971 Apr;21(4):723–725. doi: 10.1128/am.21.4.723-725.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Green J. A., Stanton G. J., Goode J., Baron S. Vesicular stomatitis virus plaque production in monolayer cultures with liquid overlay medium: description and adaptation to a one-day, human interferon-plaque. J Clin Microbiol. 1976 Dec;4(6):479–485. doi: 10.1128/jcm.4.6.479-485.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jordan G. W. Quantitative aspects of interferon-induced plaque reduction: kinetics of interferon action. Virology. 1972 May;48(2):425–432. doi: 10.1016/0042-6822(72)90053-0. [DOI] [PubMed] [Google Scholar]
  4. LINDENMANN J., GIFFORD G. E. Studies on vaccinia virus plaque formation and its inhibition by interferon. III. A simplified plaque inhibition assay of interferon. Virology. 1963 Mar;19:302–309. doi: 10.1016/0042-6822(63)90068-0. [DOI] [PubMed] [Google Scholar]
  5. MADIN S. H., DARBY N. B., Jr Established kidney cell lines of normal adult bovine and ovine origin. Proc Soc Exp Biol Med. 1958 Jul;98(3):574–576. doi: 10.3181/00379727-98-24111. [DOI] [PubMed] [Google Scholar]
  6. Richmond J. Y., Polatnick J., Knudsen R. C. Microassay for interferon, using [3H]uridine, microculture plates, and a multiple automated sample harvester. Appl Environ Microbiol. 1980 Apr;39(4):823–827. doi: 10.1128/aem.39.4.823-827.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rubinstein M., Rubinstein S., Familletti P. C., Miller R. S., Waldman A. A., Pestka S. Human leukocyte interferon: production, purification to homogeneity, and initial characterization. Proc Natl Acad Sci U S A. 1979 Feb;76(2):640–644. doi: 10.1073/pnas.76.2.640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sedmak J. J., Grossberg S. E., Jameson P. The neuraminidase yield-reduction bioassay of human other interferons. Proc Soc Exp Biol Med. 1975 Jun;149(2):433–438. doi: 10.3181/00379727-149-38822. [DOI] [PubMed] [Google Scholar]
  9. Vilcek J., Havell E. A. Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3909–3913. doi: 10.1073/pnas.70.12.3909. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES